Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Research Grants
None
Living Proof
I was told I had cancer and that I must expect to die soon. Almost eight years later I still do my job and enjoy life. I have not had conventional treatment. Did my cancer simply disappear? Did I do nothing? Far from it. A number of things happened, some by accident, most by design. Michael Gearin-Tosh is diagnosed with cancer at the age of fifty-four. The doctors urge immediate treatment. He refuses. Intuitively, not on the basis of reason. But as the days pass, Gearin-Tosh falls back on his habits as a scholar of literature. He begins to probe the experts' words and the meaning behind medical phrases. He tries to relate what each doctor says -- and does not say -- to the doctor's own tempe...
Tales from the Georgia Tech Sideline
In this reissue of Tales from the Georgia Tech Sideline, former quarterback Kim King shares stories from his unique half-century involvement with Yellow Jackets football. As a child growing up in Atlanta, King watched Coach Bobby Dodd’s great Tech teams of the 1950s play in historic Grant Field. A highly recruited high school quarterback, King went to Tech and became the star quarterback from 1965–67. “The Young Left-Hander,” as late Tech radio announcer Al Ciraldo called King, led the Jackets to two bowl games and was Bobby Dodd’s last quarterback before he retired after the 1966 season. King’s involvement with Tech football did not end with his graduation. In 1974 he joined Cir...
Progress in Oncology 2001
Medicine
The National Cancer Institute Early Detection Research Network
A field in cancer research and diagnosis is based on the concept of stem/progenitor cells as being the primary targets of neoplastic transformation - 'tumor stem cells'(TSC). It is believed that similar to normal tissue organization, tumor progression is driven by the TSC component.
The Myeloma Survival Guide
The Diagnosis Is Myeloma, Now What? is a patient survival guide and essential resource featuring expert advice on how to deal with every aspect of a myeloma diagnosis, from creating your treatment team to choosing treatment options and navigating financial issues. It will: Clarify the path to available treatment options Teach coping skills to patients and those close to them Minimize myeloma's fear and pain Demonstrate the practicality of hope.
Handbook of Statistics in Clinical Oncology, Third Edition
Many new challenges have arisen in the area of oncology clinical trials. New cancer therapies are often based on cytostatic or targeted agents, which pose new challenges in the design and analysis of all phases of trials. The literature on adaptive trial designs and early stopping has been exploding. Inclusion of high-dimensional data and imaging techniques have become common practice, and statistical methods on how to analyse such data have been refined in this area. A compilation of statistical topics relevant to these new advances in cancer research, this third edition of Handbook of Statistics in Clinical Oncology focuses on the design and analysis of oncology clinical trials and transla...
Frontiers of Biostatistical Methods and Applications in Clinical Oncology
This book presents the state of the art of biostatistical methods and their applications in clinical oncology. Many methodologies established today in biostatistics have been brought about through its applications to the design and analysis of oncology clinical studies. This field of oncology, now in the midst of evolution owing to rapid advances in biotechnologies and cancer genomics, is becoming one of the most promising disease fields in the shift toward personalized medicine. Modern developments of diagnosis and therapeutics of cancer have also been continuously fueled by recent progress in establishing the infrastructure for conducting more complex, large-scale clinical trials and obser...
Molecular Biology of B-Cell and T-Cell Development
Despite the tremendous diversity of the cells of the hematopoietic system, they are all derived from common precursor cells that are generated in the fetus and persist into adult life. In this regard, Band T lymphocytes, which comprise the two arms of the antigen-specific and inducible immune system, though functionally very different, are descendants of the same stem cell precursor. In the past several years, we have witnessed an explosion of information regarding the process by which differentiation of B-and T-cells from stem cells occurs. This information, like the answers to most important biological questions, has come from multiple and diverse directions. Because all hematopoietic cell...
